Cargando…
ST2: Current status
Cardiovascular diseases are leading cause of mortality and morbidity, and are responsible for 1 out of every 6 deaths in the United States.(1) Cardiac remodeling is an important determinant of long term outcomes and occurrence of heart failure (HF). Many times one requires additional tools like biom...
Autores principales: | Dattagupta, Aditi, Immaneni, Sathyamurthy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097168/ https://www.ncbi.nlm.nih.gov/pubmed/30122246 http://dx.doi.org/10.1016/j.ihj.2018.03.001 |
Ejemplares similares
-
S-Amlodipine: An Isomer with Difference—Time to Shift from Racemic Amlodipine
por: Dalal, Jamshed, et al.
Publicado: (2018) -
Comparison of plasma adiponectin & certain inflammatory markers in angiographically proven coronary artery disease patients with & without diabetes – A study from India
por: Kumpatla, Satyavani, et al.
Publicado: (2014) -
Ivabradine: Evidence and current role in cardiovascular diseases and other emerging indications
por: Sathyamurthy, I., et al.
Publicado: (2018) -
Heart Rate in Hypertension: Review and Expert Opinion
por: Dalal, Jamshed, et al.
Publicado: (2019) -
Risk Management for the 21st Century: Current Status and Future Needs
por: Mouchantaf, Rania, et al.
Publicado: (2021)